Rehmann Capital Advisory Group’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$910K Sell
13,186
-961
-7% -$66.3K 0.06% 231
2025
Q1
$982K Sell
14,147
-113
-0.8% -$7.85K 0.06% 223
2024
Q4
$1.23M Buy
14,260
+415
+3% +$35.7K 0.08% 186
2024
Q3
$1.65M Sell
13,845
-316
-2% -$37.6K 0.11% 145
2024
Q2
$2.02M Sell
14,161
-437
-3% -$62.4K 0.14% 121
2024
Q1
$1.87M Sell
14,598
-454
-3% -$58.3K 0.14% 121
2023
Q4
$1.56M Sell
15,052
-39
-0.3% -$4.04K 0.13% 130
2023
Q3
$1.37M Sell
15,091
-1,283
-8% -$117K 0.13% 126
2023
Q2
$1.32M Sell
16,374
-278
-2% -$22.5K 0.12% 139
2023
Q1
$1.33M Sell
16,652
-640
-4% -$50.9K 0.12% 140
2022
Q4
$1.17M Sell
17,292
-1,058
-6% -$71.6K 0.12% 151
2022
Q3
$914K Sell
18,350
-342
-2% -$17K 0.1% 174
2022
Q2
$1.04M Buy
18,692
+838
+5% +$46.7K 0.11% 157
2022
Q1
$994K Buy
17,854
+1,208
+7% +$67.2K 0.09% 190
2021
Q4
$932K Sell
16,646
-1,012
-6% -$56.7K 0.09% 201
2021
Q3
$848K Sell
17,658
-44
-0.2% -$2.11K 0.08% 214
2021
Q2
$744K Buy
17,702
+112
+0.6% +$4.71K 0.07% 233
2021
Q1
$593K Buy
17,590
+22
+0.1% +$742 0.06% 251
2020
Q4
$614K Sell
17,568
-68
-0.4% -$2.38K 0.07% 229
2020
Q3
$612K Sell
17,636
-300
-2% -$10.4K 0.08% 217
2020
Q2
$587K Sell
17,936
-1,010
-5% -$33.1K 0.08% 211
2020
Q1
$570K Buy
+18,946
New +$570K 0.09% 180
2019
Q3
$61.3K Sell
2,372
-8
-0.3% -$207 0.01% 569
2019
Q2
$60.8K Buy
2,380
+510
+27% +$13K 0.01% 767
2019
Q1
$48.9K Buy
1,870
+254
+16% +$6.65K 0.01% 818
2018
Q4
$37.2K Buy
1,616
+36
+2% +$829 0.01% 684
2018
Q3
$37.2K Sell
1,580
-2
-0.1% -$47 0.01% 913
2018
Q2
$36.5K Sell
1,582
-594
-27% -$13.7K 0.01% 889
2018
Q1
$54K Buy
+2,176
New +$54K 0.01% 738